Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer

被引:28
作者
Chen, Feilong [1 ]
Xiao, Mei [2 ]
Hu, Shaofan [3 ]
Wang, Meng [3 ]
机构
[1] Chengdu Sport Univ, Inst Sports Med & Hlth, Expert Ctr Sichuan Prov, Sports Med Key Lab Sichuan Prov, Chengdu, Peoples R China
[2] Chongqing Univ, Coll Bioengn, Chongqing, Peoples R China
[3] Third Mil Med Univ, Mil Med Univ 3, Dept Biochem & Mol Biol, Chongqing, Peoples R China
基金
中国博士后科学基金;
关键词
Keap1; Nrf2; cancer; structure; function; transcriptional regulation; prevention; clinical; TRANSCRIPTION FACTOR NRF2; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; SIGNALING PATHWAY; ANTIOXIDANT RESPONSE; PROTEASOMAL DEGRADATION; MOLECULAR-MECHANISMS; STRUCTURAL BASIS; LUNG-CANCER; ACTIVATION;
D O I
10.3389/fonc.2024.1381467
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Keap1-Nrf2 signaling pathway is a major regulator of the cytoprotective response, participating in endogenous and exogenous stress caused by ROS (reactive oxygen species). Nrf2 is the core of this pathway. We summarized the literature on Keap1-Nrf2 signaling pathway and summarized the following three aspects: structure, function pathway, and cancer and clinical application status. This signaling pathway is similar to a double-edged sword: on the one hand, Nrf2 activity can protect cells from oxidative and electrophilic stress; on the other hand, increasing Nrf2 activity can enhance the survival and proliferation of cancer cells. Notably, oxidative stress is also considered a marker of cancer in humans. Keap1-Nrf2 signaling pathway, as a typical antioxidant stress pathway, is abnormal in a variety of human malignant tumor diseases (such as lung cancer, liver cancer, and thyroid cancer). In recent years, research on the Keap1-Nrf2 signaling pathway has become increasingly in-depth and detailed. Therefore, it is of great significance for cancer prevention and treatment to explore the molecular mechanism of the occurrence and development of this pathway.
引用
收藏
页数:12
相关论文
共 137 条
[1]   Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents [J].
Abed, Dhulfiqar Ali ;
Goldstein, Melanie ;
Albanyan, Haifa ;
Jin, Huijuan ;
Hu, Longqin .
ACTA PHARMACEUTICA SINICA B, 2015, 5 (04) :285-299
[2]   Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling [J].
Adam, Julie ;
Hatipoglu, Emine ;
O'Flaherty, Linda ;
Ternette, Nicola ;
Sahgal, Natasha ;
Lockstone, Helen ;
Baban, Dilair ;
Nye, Emma ;
Stamp, Gordon W. ;
Wolhuter, Kathryn ;
Stevens, Marcus ;
Fischer, Roman ;
Carmeliet, Peter ;
Maxwell, Patrick H. ;
Pugh, Chris W. ;
Frizzell, Norma ;
Soga, Tomoyoshi ;
Kessler, Benedikt M. ;
El-Bahrawy, Mona ;
Ratcliffe, Peter J. ;
Pollard, Patrick J. .
CANCER CELL, 2011, 20 (04) :524-537
[3]   Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1/NRF2/NQO1 activation [J].
Aghagolzadeh, Parisa ;
Radpour, Ramin ;
Bachtler, Matthias ;
van Goor, Harry ;
Smith, Edward R. ;
Lister, Adam ;
Odermatt, Alex ;
Feelisch, Martin ;
Pasch, Andreas .
ATHEROSCLEROSIS, 2017, 265 :78-86
[4]   miR-432 Induces NRF2 Stabilization by Directly Targeting KEAP1 [J].
Akdemir, Burak ;
Nakajima, Yasuaki ;
Inazawa, Johji ;
Inoue, Jun .
MOLECULAR CANCER RESEARCH, 2017, 15 (11) :1570-1578
[5]   Role of Antioxidants and Natural Products in Inflammation [J].
Arulselvan, Palanisamy ;
Fard, Masoumeh Tangestani ;
Tan, Woan Sean ;
Gothai, Sivapragasam ;
Fakurazi, Sharida ;
Norhaizan, Mohd Esa ;
Kumar, S. Suresh .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2016, 2016
[6]   Exploring the role of Nrf2 signaling in glioblastoma multiforme [J].
Awuah, Wireko Andrew ;
Toufik, Abdul-Rahman ;
Yarlagadda, Rohan ;
Mikhailova, Tatiana ;
Mehta, Aashna ;
Huang, Helen ;
Kundu, Mrinmoy ;
Lopes, Leilani ;
Benson, Sylvester ;
Mykola, Lyndin ;
Vladyslav, Sikora ;
Alexiou, Athanasios ;
Alghamdi, Badrah S. ;
Hashem, Anwar M. ;
Ashraf, Ghulam Md .
DISCOVER ONCOLOGY, 2022, 13 (01)
[7]   High-throughput Phenotyping of Lung Cancer Somatic Mutations [J].
Berger, Alice H. ;
Brooks, Angela N. ;
Wu, Xiaoyun ;
Shrestha, Yashaswi ;
Chouinard, Candace ;
Piccioni, Federica ;
Bagul, Mukta ;
Kamburov, Atanas ;
Imielinski, Marcin ;
Hogstrom, Larson ;
Zhu, Cong ;
Yang, Xiaoping ;
Pantel, Sasha ;
Sakai, Ryo ;
Watson, Jacqueline ;
Kaplan, Nathan ;
Campbell, Joshua D. ;
Singh, Shantanu ;
Root, David E. ;
Narayan, Rajiv ;
Natoli, Ted ;
Lahr, David L. ;
Tirosh, Itay ;
Tamayo, Pablo ;
Getz, Gad ;
Wong, Bang ;
Doench, John ;
Subramanian, Aravind ;
Golub, Todd R. ;
Meyerson, Matthew ;
Boehm, Jesse S. .
CANCER CELL, 2016, 30 (02) :214-228
[8]   N-Terminal Proteoforms in Human Disease [J].
Bogaert, Annelies ;
Fernandez, Esperanza ;
Gevaert, Kris .
TRENDS IN BIOCHEMICAL SCIENCES, 2020, 45 (04) :308-320
[9]   Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer [J].
Camina, Nuria ;
Penning, Trevor M. .
BRITISH JOURNAL OF CANCER, 2022, 126 (09) :1244-1252
[10]   Wilms Tumor Gene on X Chromosome (WTX) Inhibits Degradation of NRF2 Protein through Competitive Binding to KEAP1 Protein [J].
Camp, Nathan D. ;
James, Richard G. ;
Dawson, David W. ;
Yan, Feng ;
Davison, James M. ;
Houck, Scott A. ;
Tang, Xiaobo ;
Zheng, Ning ;
Major, Michael B. ;
Moon, Randall T. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (09) :6539-6550